Cavendish Impact Capital manage a suite of Impact Capital Funds designed to allocate critical capital resources to confront and combat some of humankind’s most pressing global challenges. The initial fund in the suite, The Cavendish Impact Capital Life Science Fund, will provide vital capital and a path to the marketplace for early-stage health
and life science companies whose innovations have the potential to provide a transformational impact on disease prevention, diagnosis or treatment.
Website:www.cavendishimpactcapital.com/
Industries:
Artificial Intelligence
Big Data
Biotechnology
Clinical Trials
Genetics
Machine Learning
Medical
Pharmaceutical
Health Care
Medical Device
Health Diagnostics
Wellness
Investor Types:
Venture Capital
Investment Stages:
Location:
Pennsylvania, United States
Contact information:
